UA89630C2 - Схема комбинированного дозирования для эритропоэтина - Google Patents
Схема комбинированного дозирования для эритропоэтинаInfo
- Publication number
- UA89630C2 UA89630C2 UAA200610352A UAA200610352A UA89630C2 UA 89630 C2 UA89630 C2 UA 89630C2 UA A200610352 A UAA200610352 A UA A200610352A UA A200610352 A UAA200610352 A UA A200610352A UA 89630 C2 UA89630 C2 UA 89630C2
- Authority
- UA
- Ukraine
- Prior art keywords
- dosing regimen
- erythropoietin
- epo
- combination dosing
- reticulocytes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретение касается применения эритропоэтина (ЭПО) для лечения состояний, которые нуждаются в повышении общего количества эритроцитов и концентрации гемоглобина у пациентов, которые нуждаются в таком лечении, путем введения указанному субъекту соответственно схеме комбинированного дозирования двух экспозиций терапевтически эффективного количества ЭПО, которое отличается тем, что первую экспозицию вводят в виде одиночной дозы в диапазоне приблизительно от 150 IU/кг приблизительно до 2400 IU/кг, а вторую экспозицию вводят в виде одиночной или множественных доз низкого уровня, не превышающих приблизительно 100 IU/кг/пор, и вторую экспозицию инициируют в пределах приблизительно от 3 до 10 суток после первой.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55692304P | 2004-03-26 | 2004-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA89630C2 true UA89630C2 (ru) | 2010-02-25 |
Family
ID=34964370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200610352A UA89630C2 (ru) | 2004-03-26 | 2005-03-24 | Схема комбинированного дозирования для эритропоэтина |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20050267026A1 (ru) |
| EP (1) | EP1737484A1 (ru) |
| JP (1) | JP2007530578A (ru) |
| KR (1) | KR20070015549A (ru) |
| CN (1) | CN1960745A (ru) |
| AU (1) | AU2005231307A1 (ru) |
| BR (1) | BRPI0509239A (ru) |
| CA (1) | CA2561222A1 (ru) |
| CR (1) | CR8705A (ru) |
| EA (1) | EA010889B1 (ru) |
| EC (1) | ECSP066885A (ru) |
| IL (1) | IL178288A0 (ru) |
| MX (1) | MXPA06011084A (ru) |
| NO (1) | NO20064908L (ru) |
| UA (1) | UA89630C2 (ru) |
| WO (1) | WO2005097167A1 (ru) |
| ZA (1) | ZA200608877B (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150164991A1 (en) * | 2013-11-01 | 2015-06-18 | Vanderbilt University | Method and Kit for Evaluating and Monitoring a Treatment Program for Anemia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2248215C2 (ru) * | 1999-05-11 | 2005-03-20 | Орто-Макнейл Фармасьютикал, Инк. | Фармакокинетическое и фармакодинамическое моделирование введения эритропоэтина |
| KR100693263B1 (ko) * | 1999-07-22 | 2007-03-13 | 아벤티스 파마슈티칼스 인크. | 다중 투여형 에리트로포이에틴 제형 |
| EP1525889A1 (en) * | 2000-05-15 | 2005-04-27 | F. Hoffmann-La Roche Ag | Liquid pharmaceutical composition containing an erythropoietin derivative |
| US7078376B1 (en) * | 2000-08-11 | 2006-07-18 | Baxter Healthcare S.A. | Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
-
2005
- 2005-03-24 BR BRPI0509239-6A patent/BRPI0509239A/pt not_active IP Right Cessation
- 2005-03-24 US US11/088,284 patent/US20050267026A1/en not_active Abandoned
- 2005-03-24 EA EA200601782A patent/EA010889B1/ru not_active IP Right Cessation
- 2005-03-24 JP JP2007505184A patent/JP2007530578A/ja active Pending
- 2005-03-24 UA UAA200610352A patent/UA89630C2/ru unknown
- 2005-03-24 AU AU2005231307A patent/AU2005231307A1/en not_active Abandoned
- 2005-03-24 MX MXPA06011084A patent/MXPA06011084A/es unknown
- 2005-03-24 KR KR1020067022204A patent/KR20070015549A/ko not_active Application Discontinuation
- 2005-03-24 EP EP05731453A patent/EP1737484A1/en not_active Ceased
- 2005-03-24 WO PCT/US2005/009873 patent/WO2005097167A1/en active Application Filing
- 2005-03-24 CA CA002561222A patent/CA2561222A1/en not_active Abandoned
- 2005-03-24 CN CNA2005800171911A patent/CN1960745A/zh active Pending
-
2006
- 2006-09-25 IL IL178288A patent/IL178288A0/en unknown
- 2006-09-26 EC EC2006006885A patent/ECSP066885A/es unknown
- 2006-10-25 CR CR8705A patent/CR8705A/es not_active Application Discontinuation
- 2006-10-25 ZA ZA200608877A patent/ZA200608877B/en unknown
- 2006-10-26 NO NO20064908A patent/NO20064908L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20064908L (no) | 2006-12-15 |
| BRPI0509239A (pt) | 2007-09-04 |
| JP2007530578A (ja) | 2007-11-01 |
| EA010889B1 (ru) | 2008-12-30 |
| US20050267026A1 (en) | 2005-12-01 |
| CA2561222A1 (en) | 2005-10-20 |
| CN1960745A (zh) | 2007-05-09 |
| WO2005097167A1 (en) | 2005-10-20 |
| MXPA06011084A (es) | 2007-03-21 |
| ZA200608877B (en) | 2008-06-25 |
| AU2005231307A1 (en) | 2005-10-20 |
| EA200601782A1 (ru) | 2007-04-27 |
| ECSP066885A (es) | 2006-11-24 |
| EP1737484A1 (en) | 2007-01-03 |
| IL178288A0 (en) | 2006-12-31 |
| KR20070015549A (ko) | 2007-02-05 |
| CR8705A (es) | 2008-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG146682A1 (en) | Modulation of eif4e expression | |
| NO20060955L (no) | Farmasoytisk sammensetning som er nyttig til stamcellemobilisering | |
| EP1604010A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING ICAM-1 GENE BY LOW INHIBITION RNA | |
| ECSP055864A (es) | Derivados sustituidos del pirrolo-pirazol como inhibidores de la quinasa | |
| SG149061A1 (en) | Definitive endoderm | |
| MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
| MX339068B (es) | Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias. | |
| SG160364A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
| WO2006000448A3 (en) | Fc-INTERFERON-BETA FUSION PROTEINS | |
| MX2009004321A (es) | Preparacion novedosa de levadura enriquecida en vitamina d2, metodo para su produccion y uso de la misma. | |
| WO2008067389A3 (en) | Modulation of sod protein synthesis for the treatment of neurodegenerative diseases | |
| SG131943A1 (en) | Specific binding agents to hepatocyte growth factor | |
| WO2006073890A3 (en) | Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis | |
| NZ609201A (en) | Means and methods for treating dlbcl | |
| WO2005094370A3 (en) | Oligonucleotide complex compositions and methods of use as gene alteration tools | |
| ATE419277T1 (de) | Faktor-ixa-spezifische antikörper, die faktor- viiia-ähnliche wirkung zeigen | |
| ATE367167T1 (de) | Aufbereitung von aldesleukin zur pharmazeutischen verwendung | |
| BR0312099A (pt) | Uso de toxina bolutìnica, bem como composição farmacêutica | |
| MX2009002715A (es) | Metodos para mejorar la funcion cognoscitiva. | |
| WO2023150493A3 (en) | Cell therapy for diabetes | |
| WO2005089426A3 (en) | Method of treating sepsis | |
| WO2005094355A3 (en) | Methods for altering protein production rates | |
| UA89630C2 (ru) | Схема комбинированного дозирования для эритропоэтина | |
| BR0313588A (pt) | Métodos para o tratamento da demência com base em apo e genótipo | |
| WO2006065793A3 (en) | TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS |